CIP
ABMD

Chartwell Investment Partners’s Abiomed Inc ABMD Stock Holding History

Chartwell Investment Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,095
Closed -$285K – 425
2019
Q2 		$285K Sell
1,095
-229
-17% -$60.8K 0.01% 404
2019
Q1 		$378K Buy
1,324
+63
+5% +$20.9K 0.01% 422
2018
Q4 		$410K Hold
1,261
– – 0.01% 429
2018
Q3 		$567K Hold
1,261
– – 0.02% 454
2018
Q2 		$516K Buy
+1,261
New +$457K 0.02% 471

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Chartwell Investment Partners's ABMD Position: Q3 2019 in Review

Chartwell Investment Partners sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,095 shares — an estimated $285K sold.

Chartwell Investment Partners first reported a position in ABMD in Q2 2018 and held it in 5 quarters. The position peaked at $567K in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Chartwell Investment Partners reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Chartwell Investment Partners sold 1,095 Abiomed Inc shares in Q3 2019, an estimated $285K.
  • Chartwell Investment Partners first reported a position in Abiomed Inc in Q2 2018 and held it in 5 quarters.
  • Chartwell Investment Partners's Abiomed Inc position peaked at $567K in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Chartwell Investment Partners's 13F filing for Q3 2019, filed 29 Oct 2019.